Видео ютуба по тегу Periop Durvalumab

NIAGARA Trial - Periop Durvalumab with Neoad Chemo Resectable Muscle-Invasive Bladder Cancer
NIAGARA Trial - Periop Durvalumab with Neoad Chemo Resectable Muscle-Invasive Bladder Cancer
Perioperative Durvalumab in Bladder Cancer | NEJM
Perioperative Durvalumab in Bladder Cancer | NEJM
AEGEAN Trial: Perioperative Durvalumab for NSCLC - OncTalk Lung 2023
AEGEAN Trial: Perioperative Durvalumab for NSCLC - OncTalk Lung 2023
MATTERHORN: Perioperative Durvalumab Plus FLOT in Resectable Gastric and GEJ Adenocarcinoma
MATTERHORN: Perioperative Durvalumab Plus FLOT in Resectable Gastric and GEJ Adenocarcinoma
NIAGARA: ctDNA in Patients With MIBC Who Received Perioperative Durvalumab
NIAGARA: ctDNA in Patients With MIBC Who Received Perioperative Durvalumab
Perioperative durvalumab in addition to neoadjuvant chemotherapy shows positive results in patie...
Perioperative durvalumab in addition to neoadjuvant chemotherapy shows positive results in patie...
Results from the PACIFIC study: durvalumab with chemoradiation for the treatment of NSCLC
Results from the PACIFIC study: durvalumab with chemoradiation for the treatment of NSCLC
PACIFIC trial of durvalumab for lung cancer
PACIFIC trial of durvalumab for lung cancer
NIAGARA: perioperative durvalumab with neoadjuvant chemotherapy in MIBC
NIAGARA: perioperative durvalumab with neoadjuvant chemotherapy in MIBC
AEGEAN Trial: Perioperative Durvalumab & ctDNA Clearance in Resectable NSCLC – WCLC/ESMO 2024
AEGEAN Trial: Perioperative Durvalumab & ctDNA Clearance in Resectable NSCLC – WCLC/ESMO 2024
Dr. Bazhenova on the PACIFIC Trial With Durvalumab in NSCLC
Dr. Bazhenova on the PACIFIC Trial With Durvalumab in NSCLC
Tremelimumab and durvalumab therapy in lung cancer
Tremelimumab and durvalumab therapy in lung cancer
Perioperative durvalumab plus FLOT improves outcomes in gastric cancer
Perioperative durvalumab plus FLOT improves outcomes in gastric cancer
Perioperative durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancers
Perioperative durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancers
Locally Advanced NSCLC: Durvalumab and the PACIFIC Trial
Locally Advanced NSCLC: Durvalumab and the PACIFIC Trial
Durvalumab improves PFS in stage III lung cancer
Durvalumab improves PFS in stage III lung cancer